Selectively activated PRP exerts differential effects on tendon stem/progenitor cells and tendon healing

• Published in: Journal of tissue engineering Vol. 10; p. 2041731418820034
• Main Authors: Zhang, Jianying, Nie, Daibang, Williamson, Kelly, Rocha, Jorge L, Hogan, MaCalus V, Wang, James H-C
• Format: Journal Article
• Language: English
• Published: London, England SAGE Publications 01.01.2019; Sage Publications Ltd; SAGE Publishing
• Subjects: Activation; Blood vessels; Cells (biology); Collagen; Collagen (type I); Endostatin; Fibers; Gelatinase A; Healing; Injuries; Interstitial collagenase; Matrix metalloproteinase; Matrix metalloproteinases; Metalloproteinase; Original; Progenitor cells; Proteinase; Stem cells; Tendons; Vascular endothelial growth factor; TSCs; healing; PAR1; PAR4; PRP
• ISSN: 2041-7314; 2041-7314
• DOI: 10.1177/2041731418820034

To understand the variable efficacy with platelet rich plasma (PRP) treatments for tendon injury, we determined the differential effects of proteinase-activated receptor (PAR)1- or PAR4-activated PRP (PAR1-PRP, PAR4-PRP) from humans on human patellar tendon stem/progenitor cells (TSCs) and tendon healing. We show that PAR1-PRP released VEGF, whereas PAR4-PRP released endostatin. Treatment of TSCs with PAR1-PRP increased collagen I expression and matrix metalloproteinase-1 (MMP-1), but cells treated with PAR4-PRP increased less collagen I and higher MMP-2 expression. The wound area treated with PAR4-PRP formed tendon-like tissues with well-organized collagen fibers and fewer blood vessels, while PAR1-PRP treatment resulted in the formation of blood vessels and unhealed tissues. These findings indicate that differential activation of PRP leads to different effects on TSCs and tendon healing. We suggest that based on acute or chronic type of tendon injury, selective activation of PRP should be applied in clinics in order to treat injured tendons successfully.